- Home
- ALGS vs ATCH Comparison
ALGS vs ATCH Comparison
Compare ALGS & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALGS | ATCH |
|---|---|---|
| Founded | 2018 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.0M | 29.6M |
| IPO Year | 2020 | 2024 |
Fundamental Metrics
Financial Performance| Metric | ALGS | ATCH |
|---|---|---|
| Price | $5.51 | $0.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $39.33 | $1.00 |
| AVG Volume (30 Days) | 83.9K | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.30 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $2,186,000.00 | N/A |
| Revenue This Year | $32.20 | $84.47 |
| Revenue Next Year | $4.71 | $39.32 |
| P/E Ratio | ★ N/A | $3.73 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.80 | $0.14 |
| 52 Week High | $13.69 | $1.92 |
Technical Indicators
Market Signals| Indicator | ALGS | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 48.70 | 39.76 |
| Support Level | $4.80 | $0.19 |
| Resistance Level | $6.82 | $0.21 |
| Average True Range (ATR) | 0.36 | 0.01 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 55.34 | 18.22 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
About ATCH AtlasClear Holdings Inc.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.